We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Treatment and outcomes of Enterococcus faecium bloodstream infections in solid organ transplant recipients.
- Authors
Mercuro, Nicholas J.; Gill, Christian M.; Kenney, Rachel M.; Alangaden, George J.; Davis, Susan L.
- Abstract
Optimal antimicrobial therapy for Enterococcus faecium bloodstream infection (EFBSI) in the solid organ transplant (SOT) population is not well defined. The purpose of this study was to describe the pharmacotherapy and outcomes of EFBSI in SOT patients. This was a single‐center retrospective cohort of SOT patients with EFBSI from 2013 to 2019. Susceptibility testing was performed with Vitek® 2 or Etest. Estimates of optimal DAP pharmacokinetic/pharmacodynamic exposures (dose <10 mg/kg, fAUC/MIC >27.4) were made from previously established literature and equations. Fifty‐one unique cases were included in the analysis. The median age was 61 years and liver (64%), intestinal (19%), and kidney (12%) were the most common organs transplanted. Most patients had indwelling central lines (75%) at the time of bacteremia; intra‐abdominal abscesses/fluid collections were present in 44% of patients and 8% had endocarditis. Nineteen (37%) patients had polymicrobial infections. The most common definitive antimicrobial regimens were as follows: DAP plus beta‐lactam (46%), DAP monotherapy (18%), and LZD (25%). Of the 33 patients that received DAP, 21% of E faecium isolates developed DAP resistance. 30‐day mortality was 25% overall but higher in patients who received an initial DAP dose <10 mg/kg (43% vs 13%). Vancomycin‐resistance, severity of illness, neutropenia, and source control were also associated with mortality. Inadequate DAP dosing for EFBSI may be associated with mortality in the SOT population. Larger, controlled analyses are necessary to determine the impact of optimized pharmacodynamics in this population.
- Subjects
ENTEROCOCCUS faecium; TRANSPLANTATION of organs, tissues, etc.; TREATMENT effectiveness; INFECTION; ENTEROCOCCAL infections; CATHETER-related infections
- Publication
Transplant Infectious Disease, 2020, Vol 22, Issue 2, p1
- ISSN
1398-2273
- Publication type
Article
- DOI
10.1111/tid.13251